Kliniken Ludwigsburg-Bietigheim gGmbH
9
0
0
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
11.1%
1 terminated/withdrawn out of 9 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Evaluation of "PreCut-Papillectomy" in Difficult Biliary Cannulation
Role: lead
Endoscopic Treatment of the Buried Bumper Syndrome: Comparison of the Flamingo Device Versus Standard Therapy
Role: lead
Endoscopic Resection of Non-ampullary Duodenal Adenomas: Endoscopic Mucosal Resection (EMR) vs. Endoscopic Full-thickness Resection With the 'Duodenal Full-thickness Resection Device' (dFTRD)
Role: lead
Endoscopic Treatment of Non-variceal Upper GI-bleeding With High Risk of Recurrency - OTSC (Over-the-scope-clip) Versus Standard Therapy (STING2)
Role: lead
Endoscopic Full-thickness Resection of Gastric Subepithelial Tumors With the gFTRD
Role: lead
Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)
Role: lead
Endoscopic Full Thickness Resection in the Lower GI Tract With the "Full Thickness Resection Device"
Role: lead
Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy
Role: lead
Comparison of a Plastic Stent Without Central Lumen With Self Expandable Metal Stents in Patients With Malignant Distal Biliary Obstruction
Role: lead
All 9 trials loaded